Literature DB >> 26725423

Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas.

Tuukka Veija1, Virinder Kaur Sarhadi1, Virve Koljonen2, Tom Bohling1, Sakari Knuutila3.   

Abstract

Merkel cell polyomavirus (MCV) infection underlies most Merkel cell carcinoma (MCC), a primary neuroendocrine carcinoma of the skin. While previous research has focused on MCV-positive MCC tumors, less is known about the oncogenesis in MCV-negative tumors. In this study, we analyzed mutational status of 27 MCC tumors with known MCV status for hotspot regions of 50 cancer-related genes by targeted next-generation sequencing using the Ion AmpliSeq Cancer Hotspot Panel. In addition to previously reported TP53, KIT, and PIK3CA gene mutations, we found somatic mutations in the tyrosine kinase domain of the EGFR gene in a small proportion of the cells in six tumor tissues. RB1 mutations were seen only in virus negative tumors. Hotspot mutations were more frequent in MCV-negative tumors, although the difference was not statistically significant. No clear hotspot mutation profile was observed. Novel RB1 mutations were detected only in MCV-negative tumors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Merkel cell carcinoma; mutations; next-generation sequencing

Mesh:

Year:  2015        PMID: 26725423     DOI: 10.1016/j.cancergen.2015.11.006

Source DB:  PubMed          Journal:  Cancer Genet


  11 in total

Review 1.  Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Authors:  Jürgen C Becker; Andreas Stang; Axel Zur Hausen; Nicole Fischer; James A DeCaprio; Richard W Tothill; Rikke Lyngaa; Ulla Kring Hansen; Cathrin Ritter; Paul Nghiem; Christopher K Bichakjian; Selma Ugurel; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2017-11-30       Impact factor: 6.968

2.  Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma.

Authors:  Renata Ferrarotto; Robert Cardnell; Shirley Su; Lixia Diao; A Karina Eterovic; Victor Prieto; William H Morrisson; Jing Wang; Merrill S Kies; Bonnie S Glisson; Lauren Averett Byers; Diana Bell
Journal:  Head Neck       Date:  2018-03-23       Impact factor: 3.147

3.  Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Authors:  Guilherme Rabinowits; Cecilia Lezcano; Paul J Catalano; Patricia McHugh; Hailey Becker; Megan M Reilly; Julian Huang; Ayushi Tyagi; Manisha Thakuria; Scott C Bresler; Lynette M Sholl; Geoffrey I Shapiro; Robert Haddad; James A DeCaprio
Journal:  Oncologist       Date:  2018-02-14

Review 4.  Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Authors:  Daniela Femia; Natalie Prinzi; Andrea Anichini; Roberta Mortarini; Federico Nichetti; Francesca Corti; Martina Torchio; Giorgia Peverelli; Filippo Pagani; Andrea Maurichi; Ilaria Mattavelli; Massimo Milione; Nice Bedini; Ambra Corti; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

5.  Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.

Authors:  Kelly L Harms; Lili Zhao; Bryan Johnson; Xiaoming Wang; Shannon Carskadon; Nallasivam Palanisamy; Daniel R Rhodes; Rahul Mannan; Josh N Vo; Jae Eun Choi; May P Chan; Douglas R Fullen; Rajiv M Patel; Javed Siddiqui; Vincent T Ma; Steven Hrycaj; Scott A McLean; Tasha M Hughes; Christopher K Bichakjian; Scott A Tomlins; Paul W Harms
Journal:  Clin Cancer Res       Date:  2021-02-05       Impact factor: 12.531

6.  Mutational Landscape of Virus- and UV-Associated Merkel Cell Carcinoma Cell Lines Is Comparable to Tumor Tissue.

Authors:  Kai Horny; Patricia Gerhardt; Angela Hebel-Cherouny; Corinna Wülbeck; Jochen Utikal; Jürgen C Becker
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

7.  A Novel Case of Gorlin Syndrome Mosaicism Involving an SMO Gene Mutation: Clinical, Histological and Molecular Analysis of Basaloid Tumours.

Authors:  Meriem Ighilahriz; Sergey Nikolaev; Andrey A Yurchenko; Maxime Battistella; Samia Mourah; Fanélie Jouenne; Emanuelle Bourrat; Nicole Basset-Seguin
Journal:  Acta Derm Venereol       Date:  2021-04-22       Impact factor: 3.875

8.  Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.

Authors:  Philip R Cohen; Brett N Tomson; Sheryl K Elkin; Erica Marchlik; Jennifer L Carter; Razelle Kurzrock
Journal:  Oncotarget       Date:  2016-04-26

9.  Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.

Authors:  Tuukka Veija; Virve Koljonen; Tom Bohling; Mia Kero; Sakari Knuutila; Virinder Kaur Sarhadi
Journal:  BMC Cancer       Date:  2017-03-31       Impact factor: 4.430

10.  Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts.

Authors:  Bin Fang; Aarthi Kannan; Stephanie Zhao; Quy H Nguyen; Samuel Ejadi; Maki Yamamoto; J Camilo Barreto; Haibo Zhao; Ling Gao
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.